Barinthus Biotherapeutics Plc ADR (BRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Operating Expenses | 11,019 | 6,075 | 11,565 | 15,066 | 23,324 |
| Operating Income | -11,019 | -6,075 | -11,565 | -15,066 | -23,324 |
| Interest Expense | 14 | 13 | 13 | 13 | 12 |
| Other Income | 411 | 538 | 418 | 437 | 2,185 |
| Pre-tax Income | -10,622 | -5,550 | -11,160 | -14,642 | -21,151 |
| Income Tax | -23 | -16 | -57 | -71 | -25 |
| Net Income Continuous | -10,599 | -5,534 | -11,103 | -14,571 | -21,126 |
| Minority Interests | -19 | -3 | -13 | -5 | -2 |
| Net Income | $-10,580 | $-5,531 | $-11,090 | $-14,566 | $-21,124 |
| EPS Basic Total Ops | -0.26 | -0.14 | -0.27 | -0.36 | -0.52 |
| EPS Basic Continuous Ops | -0.26 | -0.14 | -0.27 | -0.36 | -0.52 |
| EPS Diluted Total Ops | -0.26 | -0.14 | -0.27 | -0.36 | -0.52 |
| EPS Diluted Continuous Ops | -0.26 | -0.14 | -0.27 | -0.36 | -0.52 |
| EPS Diluted Before Non-Recurring Items | -0.26 | -0.14 | -0.27 | -0.36 | -0.52 |
| EBITDA(a) | $-10,199 | $-5,219 | $-10,656 | $-14,165 | $-21,323 |